Recent Finacing
Recent Raise
Shape Biopharmaceuticals develops SHAPEnano, structurally defined 3D-optimized engineered nanoparticles that elicit patients' immune systems to produce therapeutic antibodies, enabling reduced dosing frequency and lower anti-drug antibody risk.
